SNSE
Sensei Biotherapeutics Inc
NASDAQ: SNSE · HEALTHCARE · BIOTECHNOLOGY
$26.62
-5.94% today
Updated 2026-04-30
Market cap
$39.04M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-16.72
Dividend yield
—
52W range
$5 – $37
Volume
0.1M
Sensei Biotherapeutics Inc (SNSE) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | — | — | — | — | — | — | — |
| Cost of revenue | $44000.00 | $73000.00 | $209000.00 | $685000.00 | $1.81M | $571000.00 | $551000.00 | — |
| Gross profit | $-44000.00 | $-73000.00 | $-209000.00 | $-685000.00 | $-1.81M | $-571000.00 | $-551000.00 | — |
| Gross margin | — | — | — | — | — | — | — | — |
| R&D | $8.23M | $8.35M | $11.92M | $21.66M | $30.38M | $18.30M | $18.63M | $10.96M |
| SG&A | $4.51M | $4.08M | $7.53M | $15.82M | $19.80M | $18.66M | $13.04M | $11.33M |
| Operating income | $-12.74M | $-12.44M | $-19.45M | $-37.48M | $-50.19M | $-37.06M | $-31.66M | $-22.29M |
| Operating margin | — | — | — | — | — | — | — | — |
| EBITDA | $-12.70M | $-14.41M | $-18.20M | $-35.44M | $-48.84M | $-33.39M | $-29.52M | $-20.91M |
| EBITDA margin | — | — | — | — | — | — | — | — |
| EBIT | $-12.74M | $-14.48M | $-18.41M | $-36.12M | $-50.19M | $-37.06M | $-30.07M | $-21.05M |
| Interest expense | $327000.00 | $2.26M | $1.69M | $670000.00 | $219000.00 | $144000.00 | $90000.00 | $32000.00 |
| Income tax | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-13.04M | $-16.74M | $-20.10M | $-36.79M | $-48.81M | $-34.10M | $-30.16M | $-21.09M |
| Net income growth (YoY) | — | -28.4% | -20.1% | -83.1% | -32.6% | +30.1% | +11.6% | +30.1% |
| Profit margin | — | — | — | — | — | — | — | — |